Mandate

Vinge advises Hexatronic in connection with the acquisition of Proximion

August 20, 2014

Vinge has advised Hexatronic Scandinavia AB (publ), listed on NASDAQ OMX First North, in connection with the acquisition of the shares in Proximion AB. Proximion manufactures, develops and sells optical modules and sub-systems based on Fiber Bragg Grating (FBG) technology which, among other things, facilitates long-distance transfer of data in fiber networks. The purchase price for the shares amounts to SEK 55 000 000 as well as results based supplementary purchase price in the maximum amount of SEK 8 000 000. The purchase price will be paid in cash and through newly issued shares in Hexatronic.

Vinge’s team consisted of responsible partner Anders Strid together with associates Anna Seisling and Patrik Gargolinski.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025